Gianelli et al evaluated patients with primary myelofibrosis. They combined the use of both the International Prognostic Scoring System (IPSS) with the extent of marrow fibrosis (MF). The authors are from multiple hospitals in Milan.
Parameters:
(1) International Prognostic Scoring System (IPSS)
(2) extent of myelofibrosis (MF)
|
IPSS |
Myelofibrosis |
HR |
|
low |
MF-0 |
1 |
|
|
MF-1 |
2.6 |
|
|
MF-2 |
6.7 |
|
|
MF-3 |
17 |
|
intermediate-1 |
MF-0 |
2.4 |
|
|
MF-1 |
6.2 |
|
|
MF-2 |
16 |
|
|
MF-3 |
41 |
|
intermediate-2 |
MF-0 |
5.8 |
|
|
MF-1 |
15 |
|
|
MF-2 |
38 |
|
|
MF-3 |
99 |
|
high |
MF-0 |
14 |
|
|
MF-1 |
36 |
|
|
MF-2 |
92 |
|
|
MF-3 |
238 |
Specialty: Hematology Oncology
ICD-10: ,
